Neuland Laboratories Ltd

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malabar India Fund Ltd

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

Intimation Regarding Completion Of US FDA Inspection

Intimation regarding completion of US FDA Inspection

Company Update / General View filing →

Analyst / Investor Meet - Intimation

Intimation about Schedule of Analyst / Institutional Investor Meeting on August 12, 2026

Company Update / Analyst / Investor Meet View filing →

Newspaper Publication

Copy of Newspaper Publication

Company Update / Newspaper Publication View filing →

Disclosure Under Regulation 30 Of SEBI Listing Regulations

Disclosure under Regulation 30 of SEBI Listing Regulations - Execution of deed of Corporate Guarantee

Company Update / General View filing →

Disclosure Under Regulation 30 Of SEBI Listing Regulations

Disclosure under Regulation 30 of SEBI Listing Regulations - Enhancement of manufacturing capacity

Company Update / General View filing →

Analyst / Investor Meet - Outcome

Audio Recording of the Earnings call conducted on August 5, 2026

Company Update / Analyst / Investor Meet View filing →

Shareholder Meeting / Postal Ballot-Outcome of AGM

Voting Results, Scrutinizer Report and proceeding of 42nd Annual General Meeting held on August 4, 2026

AGM/EGM / AGM View filing →

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Voting Results, Scrutinizer Report and proceedings of 42nd Annual General Meeting held on August 4, 2026

AGM/EGM / AGM View filing →

Intimation Under Regulation 30 Of SEBI Listing Regulations

Intimation under Regulation 30 of SEBI Listing Regulations

Company Update / General View filing →

Analyst / Investor Meet - Intimation

Q1FY27 Earnings Call Intimation

Company Update / Analyst / Investor Meet View filing →

Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation of Loss of Share Certificate(s)

Others / Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate View filing →

Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026

Neuland Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the unaudited financial ....

Board Meeting / Board Meeting View filing →

Newspaper Publication

Newspaper Publication regarding dispatch of notice of 42nd Annual General Meeting and Integrated Annual Report for FY 2025-26

Company Update / Newspaper Publication View filing →

Notice Of 42Nd Annual General Meeting

Notice of 42nd Annual General Meeting

AGM/EGM / AGM View filing →

Reg. 34 (1) Annual Report.

Notice of 42nd Annual General Meeting and Integrated Annual Report FY 2026

Others / Reg. 34 (1) Annual Report View filing →

Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Report for FY 2025-26

Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

Letter To The Shareholders Of The Company In Relation To The Notice Of 42Nd Annual General Meeting And Integrated Annual Report Of The Company For FY 2025-26

Letter to the Shareholder of the Company in relation to the Notice of 42nd Annual General Meeting and Integrated Annual Report of the Company for FY 2025-26

Company Update / General View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Closure of Trading Window

Closure of Trading Window

Insider Trading / SAST / Closure of Trading Window View filing →

Newspaper Publication

Copy of Newspaper Publication

Company Update / Newspaper Publication View filing →

Analyst / Investor Meet - Intimation

Intimation about Schedule of Analyst / Institutional Investor Meeting on June 11, 2026

Company Update / Analyst / Investor Meet View filing →

Analyst / Investor Meet - Intimation

Intimation about Schedule of Analyst / Institutional Investor Meeting on June 8 & 9, 2026

Company Update / Analyst / Investor Meet View filing →